ISRCTN ISRCTN49334271
DOI https://doi.org/10.1186/ISRCTN49334271
Secondary identifying numbers PIC-72-10
Submission date
03/03/2011
Registration date
15/03/2011
Last edited
14/08/2012
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Lourdes Ibañez
Scientific

Hospital Sant Joan de Deu, University of Barcelona
Esplugues, Barcelona
08950
Spain

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeScreening
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titlePharmacoKinetics of Metformin at age 9
Study acronymMPK
Study objectivesTo ascertain whether the pharmacokinetic parameters after oral metformin administration in young children are comparable to those in adults
Ethics approval(s)Review Board Hospital Sant Joan de Deu, apporved on 10th November 2010
Health condition(s) or problem(s) studiedAdvanced puberty
InterventionThe patients were sampled after being admitted to the hospital,every 45 minutes for 3 hours and then 4, 6, 8, 10 and 12 hours after metformin intake, 850 mg/d.

The girls were started on metformin at a mean age of 9 years.
Intervention typeOther
Primary outcome measure1. Height velocity: according to local reference curves: Ferrández-Longás A, Mayayo E, Labarta JI, Bagué L, Puga B, Rueda C, Ruiz-Echarri M, Labena C. Estudio longitudinal de crecimiento y desarrollo. Centro Andrea Prader. Zaragoza 1980-2002. In ERGON, ed. Patrones de crecimiento y desarrollo en España. Atlas de gráficas y tablas., pp 61-115. Madrid: 2004
2. Pubertal status: according to Tanner standards (Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in girls. Arch Dis Child 1969; 44:291-303)
Secondary outcome measures1. Bone age: according to Greulich & Pyle
2. Uterine and ovarian size: as measured by ultrasound and according to: Griffin IJ, Cole TJ, Duncan KA, Hollman AS, Donaldson MDC. Pelvic ultrasound measurements in normal girls. Acta Paediatr 1995; 84:536-543
Overall study start date03/03/2011
Completion date12/03/2011

Eligibility

Participant type(s)Patient
Age groupChild
SexFemale
Target number of participants6
Key inclusion criteriaThe study population consisted of 6 non-obese, Caucasian girls receiving metformin (850 mg/d at dinner time) after a history of low-birthweight (Z-score ¡Ü -1.5 for gestational age) and early-normal puberty (onset of Tanner breast stage 2 at age 8 yr; increase of uterine and ovarian size by ultrasound; pubertal gonadotropin response to GnRH agonist).
Key exclusion criteria1. A family or personal history of diabetes mellitus
2. A history of precocious pubarche or the presence of other signs of androgen excess
3. Evidence for thyroid dysfunction or glucose intolerance
4. Intake of medications known to affect gonadal function or carbohydrate metabolism.
Date of first enrolment03/03/2011
Date of final enrolment12/03/2011

Locations

Countries of recruitment

  • Spain

Study participating centre

Hospital Sant Joan de Deu, University of Barcelona
Esplugues, Barcelona
08950
Spain

Sponsor information

Hospital Sant Joan de Déu, University of Barcelona (Spain)
Hospital/treatment centre

Hospital Sant Joan de Deu, Univeristy of Barcelona
c/o Lourdes Ibañez
Esplugues, Barcelona
08950
Spain

ROR logo "ROR" https://ror.org/001jx2139

Funders

Funder type

Hospital/treatment centre

Hospital Sant Joan de Déu, University of Barcelona (Spain)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/11/2011 Yes No